Darbepoetin alfa administration in patients with non-Hodgkin lymphoma and chemotherapy-induced anemia receiving (盧)CHOP

By Pettengell Ruth  

Hematology, Vol. 18, Iss. 1, 2013-01 ,pp. : 26-29

Maney Publishing

Access to resources Recommend Favorite

Occurrence of sarcoidosis subsequent to chemotherapy for non-Hodgkin's lymphoma: report of two cases

By Kornacker M.   Kraemer A.   Leo E.   Ho A.  

Annals of Hematology, Vol. 81, Iss. 2, 2002-02 ,pp. : 103-105

Springer Publishing Company

Access to resources Recommend Favorite

Bendamustine for non-Hodgkin lymphoma

By Gribben John  

Expert Review of Hematology, Vol. 6, Iss. 2, 2013-04 ,pp. : 123-125

Informa Healthcare

Access to resources Recommend Favorite

TiA1 in advanced-stage classical Hodgkin’s lymphoma: no prognostic impact for positive tumour cells or number of cytotoxic cells

By Camilleri-Broët Sophie  

Virchows Archiv, Vol. 445, Iss. 4, 2004-10 ,pp. : 344-346

Springer Publishing Company

Access to resources Recommend Favorite

Tandem myeloablative ¹³¹I-rituximab radioimmunotherapy and high-dose chemotherapy in refractory/relapsed non-Hodgkin lymphoma patients

By Deshayes Emmanuel   Kraeber-Bodéré Françoise   Vuillez Jean-Philippe   Bardiès Manuel   Teulon Isabelle   Pouget Jean-Pierre  

Immunotherapy, Vol. 5, Iss. 12, 2013-12 ,pp. : 1283-1286

Future Medicine

Access to resources Recommend Favorite